Maynard Um
-
-
-
-
-
-
-
ZAI LAB advances global pipeline with three Zoci trials by 2026 end
-
-
-
-
-
-
-
Zai Lab receives Hong Kong approval for cervical cancer drug TIVDAK
-
-
-
-
-
-
-
Zai Lab Limited (ZLAB) Presents Positive Phase 1 Data for ZL-1310
-
-
-
-
-
-
-
Smid cap biotech investors must stop chasing binary events says Cantor Fitzgerald
-
-
-
-
-
-
-
Zai Lab (ZLAB) Announces Acceptance of New Drug Application for KarXT for the Treatment of Schizophrenia
-
-
-
-
-
-
-
Zai Lab (ZLAB) Reports Positive Topline Data from Phase 3 Bridging Trial Evaluating KarXT for the Treatment of Schizophrenia in China
-
-
-
-
-
404,880 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

